Joint European Medicines Agency / Food and Drug Administration workshop for paediatric Gaucher disease type I: exploring the way forward

Date:
17/09/2012 to 18/09/2012
Location: European Medicines Agency, London, UK
Food and Drug Administration colleagues joined forces with the European Medicines Agency to host industry- and patient-organisation representatives for a unique workshop to discuss the current situation of medicine development in paediatric Gaucher disease. Participants were encouraged to consider collaborative and innovative thinking to address the current therapeutic needs in this rare disorder. Registration closed.

Documents

How useful was this page?

Add your rating